q4 adjusted earnings per share $2.26.
q4 sales rose 18.5 percent to $1.968 billion.
q4 adjusted earnings per share $0.35.
qtrly adjusted ebitda increased 19.4% to $361.2 million.
q4 adjusted earnings per share $2.26.
q4 sales rose 8.5 percent to $510.2 million.
qtrly net sales of new york style were down 4.5% to $1.8 million.
qtrly gross profit of $481.7 million, or 24.5% of net sales.
q4 adjusted ebitda $73.3 million versus refinitiv ibes estimate of $69.5 million.
q4 sales $27.8 million versus refinitiv ibes estimate of $26.7 million.
q4 sales $27.8 million versus refinitiv ibes estimate of $28.7 million.
qtrly adjusted ebitda before covid-19 expenses of $374.8 million, up 23.9%.
sees 2021 base business net sales to exceed 2019 net sales by approximately 10%.
q4 adjusted ebitda before covid-19 expenses of $77.6 million, an increase of $8.1 million or 11.7%.
qtrly adjusted ebitda before covid-19 expenses as a percentage of net sales was 19% in fiscal 2020.
qtrly gross profit of $383.1 million, or 23.1% of net sales.
